Emcure Share Price Target Today/Tomorrow 2025, 2025, 2028, 2030, 2040 All Details Emcure Pharmaceuticals Limited, based in Pune, is a leading pharmaceutical company that focuses on developing, manufacturing, and globally marketing a diverse range of pharmaceutical products across various therapeutic areas. In the MAT September 2023 data, the company held the 13th position in domestic sales among pharmaceutical firms in India and ranked fourth in market share within its designated markets. With 13 manufacturing facilities in India, Emcure Pharmaceuticals produces a wide array of products such as tablets, liquids, injections, and complex substances in the fields of pharmaceuticals and biopharmaceuticals.
Emcure Share Price Target 2025 To 2040 Forecast
|
YEAR |
MINIMUM PRICE (IN RUPEES) |
MAXIMUM PRICE (IN RUPEES) |
|
2025 |
₹960 |
₹1008 |
|
2025 |
₹1020 |
₹1100 |
|
2028 |
₹1090 |
₹1202 |
|
2030 |
₹1200 |
₹1280 |
|
2040 |
₹1250 |
₹1500 |
Emcure Share Price Target 2025
|
YEAR |
MINIMUM PRICE (IN RUPEES) |
MAXIMUM PRICE (IN RUPEES) |
|
2025 |
₹960 |
₹1008 |
Emcure Share Price Target 2025
|
YEAR |
MINIMUM PRICE (IN RUPEES) |
MAXIMUM PRICE (IN RUPEES) |
|
2025 |
₹1020 |
₹1100 |
Emcure Share Price Target 2028
|
YEAR |
MINIMUM PRICE (IN RUPEES) |
MAXIMUM PRICE (IN RUPEES) |
|
2025 |
₹1090 |
₹1202 |
Emcure Share Price Target 2030
|
YEAR |
MINIMUM PRICE (IN RUPEES) |
MAXIMUM PRICE (IN RUPEES) |
|
2025 |
₹1200 |
₹1280 |
Emcure Share Price Target 2040
|
YEAR |
MINIMUM PRICE (IN RUPEES) |
MAXIMUM PRICE (IN RUPEES) |
|
2025 |
₹1250 |
₹1500 |
Emcure Pharma shares jump over 4% post listing. Should you buy, sell or hold Know?
Emcure Pharmaceuticals’ shares surged by 4% to Rs 1,384 following a successful debut on the stock exchanges on Wednesday. The stock debuted at Rs 1,325 on both the NSE and BSE, surpassing the IPO price of Rs 1,008 per share by Rs 317, which is a premium of 31.4%. The strong listing was anticipated due to the immense response, with the issue being oversubscribed by nearly 68 times.
Emcure Pharma IPO Anchor Investors Details
Emcure Pharma IPO raises Rs 582.61 crore from anchor investors.
|
Bid Date |
July 2, 2025 |
|
Shares Offered |
5,779,850 |
|
Anchor Portion Size (In Cr.) |
582.61 |
|
Anchor lock-in period end date for 50% shares (30 Days) |
August 7, 2025 |
|
Anchor lock-in period end date for remaining shares (90 Days) |
October 6, 2025 |
How to apply in Emcure Pharma IPO through Zerodha?
Zerodha clients can utilize UPI as a payment portal to apply for the Emcure Pharma IPO online. To apply for the Emcure Pharma IPO, Zerodha customers must log into the Zerodha Console (back office) and complete an IPO application form. Steps to apply in Emcure Pharma IPO through Zerodha:
- Visit the Zerodha website and login to Console.
- Go to Portfolio and click the IPOs link.
- Go to the ‘Emcure Pharma IPO’ row and click the ‘Bid’ button.
- Enter your UPI ID, Quantity, and Price.
- ‘Submit’ IPO application form.
- Visit the UPI App (net banking or BHIM) to approve the mandate.
Emcure Pharma IPO Lot Size
Investors have the option to bid for at least 14 shares and in multiples of that amount. The table below shows the minimum and maximum investment amounts for retail investors and HNI in terms of shares and money.
|
Application |
Lots |
Shares |
Amount |
|
Retail (Min) |
1 |
14 |
₹14,112 |
|
Retail (Max) |
14 |
196 |
₹197,568 |
|
S-HNI (Min) |
15 |
210 |
₹211,680 |
|
S-HNI (Max) |
70 |
980 |
₹987,840 |
|
B-HNI (Min) |
71 |
994 |
₹1,001,952 |
Emcure Pharma IPO Reservation
Emcure Pharma’s IPO includes a total of 19,483,388 shares, with allocations as follows: 3,853,234 shares (19.78%) for QIB, 2,889,926 shares (14.83%) for NII, 6,743,160 shares (34.61%) for RII, 108,900 shares (0.56%) for employees, and 5,779,850 shares (29.67%) for Anchor investors. In the event of oversubscription, 481,654 RIIs will be allotted a minimum of 14 shares, while 4,587 (sNII) and 9,174 (bNII) will receive a minimum of 210 shares.
|
Investor Category |
Shares Offered |
Maximum Allottees |
|
Anchor Investor Shares Offered |
5,779,850 (29.67%) |
NA |
|
QIB Shares Offered |
3,853,234 (19.78%) |
NA |
|
NII (HNI) Shares Offered |
2,889,926 (14.83%) |
|
|
bNII > ₹10L |
1,926,618 (9.89%) |
9,174 |
|
sNII < ₹10L |
963,309 (4.94%) |
4,587 |
|
Retail Shares Offered |
6,743,160 (34.61%) |
481,654 |
|
Employee Shares Offered |
108,900 (0.56%) |
NA |
|
Total Shares Offered |
19,483,388 (100%) |
|
Key Performance Indicator
The market capitalization of Emcure Pharma IPO is Rs 19029.89 Cr.
|
KPI |
Values |
|
ROE |
16.90% |
|
ROCE |
19.37% |
|
Debt/Equity |
0.67 |
|
RoNW |
16.87% |
|
P/BV |
6.18 |
Emcure Pharmaceuticals Limited Contact Details
Emcure Pharmaceuticals Limited
Plot No. P-1 and P-2,
IT-BT Park, Phase II, M.I.D.C.,
Hinjawadi, Pune -411 057
Phone: +91 20 3507 0033
Email: [email protected]
Website: https://www.emcure.com/
Final Words
Emcure Pharma shares have witnessed a significant increase post-listing, reflecting positive market sentiment towards the company. This surge in share price indicates growing investor interest in Emcure and its potential for future growth. For investors considering whether to buy or sell Emcure shares, it’s essential to conduct thorough research and analysis to make informed decisions aligned with their investment goals. The upward momentum in Emcure’s share price suggests optimism about the company’s prospects, but individual investors should carefully assess their risk tolerance and investment strategy before making any decisions.